Sun Pharma
No plans to get into vaccine production as it requires separate manufacturing infra: Sun Pharma
Commenting on the company's Halol plant, which has been under the USFDA radar for the last few years, Shanghvi said the drug firm is waiting for the regulator to inspect the facility.
If Nifty continues to trade below 15,600, it may touch 15,510; HCL Tech, Sun Pharma look strong on charts
The larger texture of the market is still on the bullish side and likely to continue in the near term, said an analyst
Sun Pharmaceuticals rating – Buy: One-offs impacted the bottomline in Q4
Steady progress in sales of specialty products; the momentum is likely to be sustained; ‘Buy’ retained with TP raised to Rs 815
Sun Pharma Q4 net profit zooms over twofold to Rs 894.15 crore
The company had posted a net profit of Rs 399.84 crore in the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.
TCS, ICICI Bank, other must-have stocks: Time to rejig investment portfolio post Budget 2021? INTERVIEW
Investment advisor Sandip Sabharwal tells that the biggest driver of the markets now is easy liquidity which needs to be monitored.
Pharma shares regaining momentum, resuming up-trend; here’s how to shape your stock portfolio
Based on technical analysis, ICICI Direct has carved out a list of stocks that makes a multi-cap pharma stock portfolio.
Stocks to buy ahead of Budget 2021: IRCTC, HUL, Maruti, HCL Tech, more; these sectors to be in focus
Union Budget 2021 India: Ahead of Union Budget 2021, market watchers have advised a few sectors and stocks which may remain in focus during this week.
BSE Healthcare index doubles from March lows on COVID vaccine hopes; 3 healthcare stocks look set to gain
Economic indicators have started turning positive which could start the upgrade cycle and liquidity flows across Emerging Markets could remain strong which bodes well for Indian markets.
Sun Pharma share price rallies 62% from March lows; should you buy the stock? Check target prices
Sun Pharmaceuticals Industries stock has been on a gaining spree since it touched a 52-week low of Rs 315.20 in March this year
लॉकडाउन के सिंकदर! निवेशकों ने खामोशी से कमा लिए 16 लाख करोड़, अप्रैल में यहां हुई धुंआधार कमाई
अप्रैल यानी सिर्फ 1 महीने में ही शेयर बाजार ने करीब 19 फीसदी रिटर्न दे दिया.
COVID-19: कोरोना के कहर में भी कमाई कराते रहे ये शेयर, क्या आगे भी बना सकते हैं मालामाल?
कोरोना संकट में भी बीएसई 100 यानी टॉप 100 कंपनियों के कुछ शेयरों का प्रदर्शन इस साल अच्छा र
सनफार्मा: 1700 करोड़ के बाय बैक को मंजूरी, शेयर धारकों के पास 15% रिटर्न पाने का मौका
सनफार्मा ने 1700 करोड़ रुपये के शेयर बाय बैक का एलान किया है.
M-cap of top seven companies decline by Rs 45,963 cr
The combined market valuation of top seven companies declined by Rs 45,962.77 crore last week with IT majors -- Infosys and TCS -- taking the maximum hit.
Sun Pharma enters into derma segment
The company will co-promote Suncros brand across prescription and consumer channels to drive growth Sun Pharma will focus on dermatology as the fourth engine of growth for its OTC business. As part of this growth strategy, th
Sun Pharma announces divestment of US manufacturing units
Divests two units to Frontida BioPharm
Sun Pharma sells two US-based plants to Frontida BioPharm
Drug major Sun Pharmaceutical Industries has sold two of its US-based manufacturing facilities along with 15 products to Frontida BioPharm Inc for an undisclosed amount.
Sun’s problems to linger on for 2-3 quarters: Jefferies
Headwinds plaguing the country's largest drug-maker Sun Pharmaceutical will continue for next two-three quarters owing to pricing pressures and regulatory issues dogging its Halol plant, says a report.
Sun Pharma revenue growth guidance at 8-10 pc for FY’17
Sun Pharma also said that its board has decided to evaluate a proposal for buyback of equity shares and will hold a meeting on June 23 for the purpose.
Sun Pharma shares fall 6% on weak sales guidance
Sun Pharmaceutical Industries shares plunged nearly 6 per cent in late morning trade on Tuesday after the pharma company posted a weaker-than expected annual sales outlook as it grappled with increased competition in the Unit
Sun Pharma Q4 profit at Rs 1,713.69 cr
Country's largest drug maker Sun Pharmaceutical Industries today reported a consolidated net profit of Rs 1,713.69 crore for the fourth quarter ended March 31, 2016.
M-cap of top 10 companies swells by Rs 98,598 cr, ITC biggest gainer
Driven by a sharp rally in the stock market last week, the combined market valuation of top- 10 most valued Indian companies soared by a whopping Rs 98,598 crore, with ITC emerging as the biggest mover.
Sun Pharma shares surge over 5% on termination of transition pact with Daiichi
Sun Pharma shares rallied after it said that the umbrella pact and transaction agreements signed with Daiichi Sankyo and its overseas subsidiaries have been terminated due to divestment of Ranbaxy by the Japanese firm.
Sun Pharma launches mobile app for asthma patients
RespiTrack seeks to enable doctors to track treatment progress of their patients and increase compliance to medication
Nine of top 10 bluechip companies lose Rs 47,932 cr in market cap
The combined market valuation of nine of the top 10 most valued Indian companies diminished by Rs 47,932.59 crore last week, with IT major TCS taking the biggest hit.
